Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Observational Study
. 2022 Mar 17;60(1):49-55.
doi: 10.2478/rjim-2021-0027. Print 2022 Mar 1.

Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience

Andrei Voiosu  1   2 , Adina Roman  3   4 , Ruxandra Pop  1 , Alina Boeriu  3   4 , Cristiana Popp  5   2 , Sabina Zurac  5   2 , Theodor Voiosu  1   2 , Daniela Dobru  3   4 , Bogdan Mateescu  1   2
Affiliations
Free article
Observational Study

Characteristics and outcomes of patients with COVID-19 and liver injury: a retrospective analysis and a multicenter experience

Andrei Voiosu et al. Rom J Intern Med. .
Free article

Abstract

Background and aims. Patients with COVID-19 frequently present abnormal elevated liver function tests of unknown clinical significance. We aimed to investigate the characteristics and factors influencing outcome in patients with confirmed SARS-CoV-2 infection and liver injury on admission.Methods. This is a retrospective observational study of patients hospitalized in two COVID units in Romania. Relevant data on clinical and laboratory parameters and medication administered during the admission were analyzed to identify predictors of a negative outcome. Patients with confirmed COVID-19 and liver function tests (LFTs) above the upper limit of normal were included in the analysis.Results. From 1,207 patients, we identified 134 patients (11%) with abnormal LFTs during hospitalization. The majority of patients had mildly elevated levels and a predominantly cholestatic pattern of liver injury. Patients who received lopinavir/ritonavir were more likely to have increased ALAT levels (p<0.0001). Sixteen patients had pre-existing chronic liver disease, and they were more likely to suffer from severe COVID-19 (p=0.009) and have a negative outcome (p<0.001), but on multivariate analysis, only the severity of COVID-19 was predictive of death (OR 69.9; 95% CI 6.4-761.4).Conclusions. Mild liver injury is relatively common in COVID-19 and possibly influenced by medication. Patients with chronic liver disease are at high risk for negative outcome, but the severity of the infection is the only predictor of death.

Keywords: COVID-19; SARS-CoV-2; antiviral therapy; drug-induced liver injury; hepatitis; hydroxychloroquine; liver injury; lopinavir/ritonavir.

PubMed Disclaimer

References

REFERENCES

    1. 1. CICHOŻ-LACH H., MICHALAK A. Liver injury in the era of COVID-19. World journal of gastroenterology 2021;27(5): 377.10.3748/wjg.v27.i5.377
    1. 2. DONG ZY, et al. The prevalence of gastrointestinal symptoms, abnormal liver function, digestive system disease and liver disease in COVID-19 infection: a systematic review and meta-analysis. Journal of Clinical Gastroenterology 2021; 55(1): 67.10.1097/MCG.0000000000001424
    1. 3. KUNUTSOR SK., LAUKKANEN JA. Markers of liver injury and clinical outcomes in COVID-19 patients: a systematic review and meta-analysis. Journal of Infection 2021; 82(1): 159–198.10.1016/j.jinf.2020.05.045
    1. 4. NARDO AD, et al. Pathophysiological mechanisms of liver injury in COVID-19. Liver International 2021; 41(1): 20–32.10.1111/liv.14730
    1. 5. JOTHIMANI D, VENUGOPAL R, ABEDIN MF, KALIAMOORTHY I, RELA M. COVID-19 and Liver [published online ahead of print, 2020 Jun 15]. J Hepatol. 2020; S0168-8278(20)30377–9.

Publication types

Substances

LinkOut - more resources